Without ex vivo activation, the passive transfer of mutated SOD1 Tregs from early disease ALS mice into ALS mice was more immunotherapeutic than the passive transfer of wild-type CD4+ T cells. This evidence concerns the gene CD4 and amyotrophic lateral sclerosis.